−33.05MXN
−3.52 BMXN
8.65 BMXN
96.28 M
About NOVOCURE LTD
Sector
Industry
CEO
Asaf Danziger
Website
Headquarters
St. Helier
Employees (FY)
1.45 K
Founded
2000
ISIN
JE00BYSS4X48
FIGI
BBG012FDDTH3
NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of NVCR/N is 275.39 MXN — it has decreased by 48.53% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange NOVOCURE LTD stocks are traded under the ticker NVCR/N.
NOVOCURE LTD is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
NVCR/N stock is 94.27% volatile and has beta coefficient of 1.55. Check out the list of the most volatile stocks — is NOVOCURE LTD there?
NVCR/N earnings for the last quarter are −8.02 MXN per share, whereas the estimation was −9.15 MXN resulting in a 12.38% surprise. The estimated earnings for the next quarter are −8.86 MXN per share. See more details about NOVOCURE LTD earnings.
NOVOCURE LTD revenue for the last quarter amounts to 2.22 B MXN despite the estimated figure of 2.24 B MXN. In the next quarter revenue is expected to reach 2.27 B MXN.
Yes, you can track NOVOCURE LTD financials in yearly and quarterly reports right on TradingView.
NVCR/N net income for the last quarter is −799.64 M MXN, while the quarter before that showed −862.56 M MXN of net income which accounts for 7.29% change. Track more NOVOCURE LTD financial stats to get the full picture.
Today NOVOCURE LTD has the market capitalization of 21.91 B, it has decreased by 6.70% over the last week.
No, NVCR/N doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NVCR/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVOCURE LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 1.45 K employees. See our rating of the largest employees — is NOVOCURE LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVOCURE LTD technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVOCURE LTD stock shows the strong sell signal. See more of NOVOCURE LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on NOVOCURE LTD future price: according to them, NVCR/N price has a max estimate of 688.31 MXN and a min estimate of 245.83 MXN. Read a more detailed NOVOCURE LTD forecast: see what analysts think of NOVOCURE LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVOCURE LTD EBITDA is −3.76 B MXN, and current EBITDA margin is −43.47%. See more stats in NOVOCURE LTD financial statements.